Romosozumab effect on neutrophil-to-lymphocyte ratio in post-menopausal women at high risk of fracture
In post-menopausal women with severe osteoporosis, 12 months of ROMO treatment was associated with a statistically significant reduction in NLR, reflecting a potential modulation of systemic inflammation, though the clinical relevance of this modest shift remains uncertain and warrants further investigation.
Authors
- Camilla Benini (ORCID: https://orcid.org/0000-0002-8082-5023)
- Francesco Pollastri (ORCID: https://orcid.org/0009-0006-1691-2196)
- Emma Pasetto
- M. Rossini
- A. Piccinelli
- Valeria Messina (ORCID: https://orcid.org/0000-0003-0397-4428)
- Mariana Diz-Lopes
- Giorgia Scagliosi
- Giovanni Adami
- Martina Teoni
- Davide Gatti
- Ombretta Viapiana
Institutions
- University of Verona (IT)
- Hospital de São João (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.55563/clinexprheumatol/toszpl
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00